Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on EBR Systems.
RELATED STOCKHEAD STORIES
News
ASX Lunch Wrap: ASX, Bitcoin take breather after yesterday’s leap; Iluka dumps on cost overrun
Health & Biotech
Scott Power: Global health markets wobble as Trump picks RFK Jr for top health role
News
Closing Bell: ASX ends Friday in style; NoviqTech explodes 180pc
Health & Biotech
EBR reports milestone quarter, final FDA review for WiSE CRT system
Health & Biotech
Health Check: Could the White House be about to welcome LSD and magic mushrooms into the Oval Office?
Health & Biotech
Five ASX healthcare companies poised for game-changing catalysts
Health & Biotech
EBR seeks key WiSE US reimbursement
Health & Biotech
Health Check: Thirsty Chimeric goes to the well for funding top-up
Health & Biotech
ASX innovators reshaping traditional medical treatments
News
Closing Bell: Another China boost for mining stocks; Odessa soars 150pc on uranium project backing
Health & Biotech
‘Closer to US commercialisation’ – EBR achieves major FDA milestone
News
Market Highlights: All eyes on another ASX record, and why investors could pile on stocks before year-end
Health & Biotech
Scott Power: Which health ‘underperformer’ just made a big move?
News
Closing Bell: ASX choppy as traders sit it out; BPM soars on Mt Gibson gold find
Health & Biotech
EBR begins $50m capital raise to commercialise WiSE leadless pacemaker
Stockhead TV
Long Shortz with EBR Systems: regulatory submission a major milestone
Health & Biotech
